Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells

por Camilla M. Grunewald, Corinna Haist, Corinna Haist, Carolin König, Patrick Petzsch, Arthur Bister, Arthur Bister, Elfriede Nößner, Constanze Wiek, Kathrin Scheckenbach, Karl Köhrer, Günter Niegisch, Helmut Hanenberg, Helmut Hanenberg, Michèle J. Hoffmann
Publicado 2021